These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28545165)

  • 61. H3.3-G34W in giant cell tumor of bone functionally aligns with the exon choice repressor hnRNPA1L2.
    Lee E; Park YJ; Lindroth AM
    Cancer Gene Ther; 2024 Aug; 31(8):1177-1185. PubMed ID: 38811797
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Locally Aggressive Giant Cell Tumor of Bone With Pulmonary Distant Metastasis and Extrapulmonary Seeding in Pregnancy.
    Murshed KA; Elsayed AM; Szabados L; Rashid S; Ammar A
    J Am Acad Orthop Surg Glob Res Rev; 2020 Jan; 4(1):. PubMed ID: 32159067
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Giant Cell Tumor of Bone Without Giant Cells with a Long Clinical Course: A Case Report.
    Takase H; Kato I; Ito J; Kawabata Y; Okabe T; Takeyama M; Fujii S
    Int J Surg Pathol; 2023 Apr; 31(2):190-194. PubMed ID: 35502834
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing.
    Lim J; Park JH; Baude A; Yoo Y; Lee YK; Schmidt CR; Park JB; Fellenberg J; Zustin J; Haller F; Krücken I; Kang HG; Park YJ; Plass C; Lindroth AM
    Sci Rep; 2017 Oct; 7(1):13459. PubMed ID: 29044188
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [New aspects on giant cell tumor of bone].
    Lüke J; Hasenfratz M; Möller P; Barth TFE
    Pathologe; 2018 Mar; 39(2):125-131. PubMed ID: 29110035
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Malignant Transformation of Giant Cell Tumour of Bone: A Review of Literature and the Experience of a Referral Centre.
    Vari S; Riva F; Onesti CE; Cosimati A; Renna D; Biagini R; Baldi J; Zoccali C; Anelli V; Annovazzi A; Covello R; Ascione A; Casini B; Ferraresi V
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I; Mancini I; Simoni A; Baldi GG; Simi L; Campanacci D; Beltrami G; Scoccianti G; D'Arienzo A; Capanna R; Franchi A
    J Clin Pathol; 2016 Mar; 69(3):240-7. PubMed ID: 26338802
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.
    Tsukamoto S; Righi A; Vanel D; Honoki K; Donati DM; Errani C
    Jpn J Clin Oncol; 2017 Nov; 47(11):1090-1096. PubMed ID: 29048579
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of giant cell tumour of bone cells for Noonan syndrome/cherubism-related mutations.
    Moskovszky L; Idowu B; Taylor R; Mertens F; Athanasou N; Flanagan A
    J Oral Pathol Med; 2013 Jan; 42(1):95-8. PubMed ID: 22725657
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
    Toledo RA; Qin Y; Cheng ZM; Gao Q; Iwata S; Silva GM; Prasad ML; Ocal IT; Rao S; Aronin N; Barontini M; Bruder J; Reddick RL; Chen Y; Aguiar RC; Dahia PL
    Clin Cancer Res; 2016 May; 22(9):2301-10. PubMed ID: 26700204
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
    Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
    PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L; Dijkstra S; van de Sande M; Gelderblom H
    Curr Opin Oncol; 2020 Jul; 32(4):332-338. PubMed ID: 32541321
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.
    Rehkämper J; Steinestel K; Jeiler B; Elges S; Hekeler E; Huss S; Sperveslage J; Hardes J; Streitbürger A; Gosheger G; Wardelmann E; Baumhoer D; Trautmann M; Hartmann W
    Oncotarget; 2018 Jul; 9(53):30106-30114. PubMed ID: 30046391
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Giant-cell tumor of bone in 2022].
    Larousserie F; Audard V; Burns R; de Pinieux G
    Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The malignant transformation after denosumab-treated giant cell tumor of bone and the H3F3A mutation syndrome].
    Gong LH; Liu WF; Shan HC; Sun XQ; Zhang M; Ding Y; Niu XH
    Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1177-1179. PubMed ID: 33152826
    [No Abstract]   [Full Text] [Related]  

  • 76. Genome-Wide Transcriptome Profiling of the Neoplastic Giant Cell Tumor of Bone Stromal Cells by RNA Sequencing.
    Lau CP; Kwok JS; Tsui JC; Huang L; Yang KY; Tsui SK; Kumta SM
    J Cell Biochem; 2017 Jun; 118(6):1349-1360. PubMed ID: 27862217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The two faces of giant cell tumor of bone.
    Scotto di Carlo F; Whyte MP; Gianfrancesco F
    Cancer Lett; 2020 Oct; 489():1-8. PubMed ID: 32502498
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
    Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
    Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.
    Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z
    BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.